SlideShare a Scribd company logo
Measures of
Disease Frequency,
Association and Impact
SEMINAR NO: 5
1
Contents
1. Rationale for measurement of health and disease
2. Tools of measurement
3. Measures of disease frequency
4. Measures of association
5. Measures of impact
6. Summary
7. References
2
Rationale
Measurement of health and disease is important due to the following reasons:
a. Need for data to guide efforts towards reducing the consequences of disease
b. To understand and assess health status of a population and its changes with time
c. Need for evidence-based decisions in healthcare
3
How do we measure disease?
4
Count Divide Compare
These are: Count, Rate, Ratio, Proportion
Count:
• Simplest and most basic form of measurement.
• It represents the number of individuals who meet the case definition.
• Limitation:
(i) Count do not consider the size of population at risk
(ii)Count do not specify the time of observation
Tools of measurement- Count
5
Count
6
Example:
Count:
Number of new
cases
Year Population
City A 58 1990 25,000
City B 35 1989-90 7,000
Divide:
City A (58/25,000)/1 year=0.00232
City B (35/7,000)/2 years= 0.0025
Compare:
City A 232/100,000 per year
City B 250/100,000 per year
Common tools of measurement used in research are – rate, ratio, proportion.
Basic formula:
• Numerator - count of an event in a population during a specific time period.
• Denominator - population pool
Tools of measurement
ꭓ 10𝑛
𝑁𝑢𝑚𝑒𝑟𝑎𝑡𝑜𝑟
𝐷𝑒𝑛𝑜𝑚𝑖𝑛𝑎𝑡𝑜𝑟
7
What is in the
denominator?
• Measures the occurrence of an event in a defined population during a given
period of time.
• It is a statement of the risk of developing a condition and is used for
comparison between different locations, time periods or groups.
• E.g., death rate and is given by the formula:
Death rate =
8
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑡ℎ𝑠 𝑖𝑛 𝑜𝑛𝑒 𝑦𝑒𝑎𝑟
𝑀𝑖𝑑 − 𝑦𝑒𝑎𝑟 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
∗ 1000
Rate
Rate- expressed per 1000 or round figure (10,000;100,000) selected according to convenience to avoid fractions.
numerator
denominator
time
multiplier
• Concept of numerator in rate: Numerator is a component of denominator in calculating a rate.
• Concept of denominator in rate: Appropriate denominator should be chosen to calculate a rate.
9
Denominator
Related to
Population
Mid year
population
Population at
risk
Person-time
Subgroups of
the
population
Related to
Total events
10
Mid -year population
• The population size changes
daily due to births, deaths or
migration.
•Mid-point refers to the
population estimated as on
first of July of a year.
Population at risk
•Focus is on the groups at risk
of disease rather than on
individuals.
• The concept of ‘population
at risk’ is restricted solely to
those who are capable of
having or acquiring the
disease or condition in
question.
Person -time
• When persons enter the
study at different times, they
are under observation for
varying time period.
•In such cases the
denominator is a
combination of persons and
time (as in person -years,
person -months, person -
weeks or man- hours).
•Person – distance is a variant
of person – time as in
passenger -miles.
Sub-groups of the population
•Denominator may be
subgroup of a population
•e.g., age, gender, occupation
etc.
These denominators have the advantage of summarizing the experience of persons with different durations of
observation or exposure.
a) Related to the population:
Example:
Mortality rate of tetanus in Monduli in 1995
Tetanus deaths: 17
Population in 1995: 58 million
Mortality rate =0.029/ 100,000 per year
The number of death due to tetanus is 2900 per 100,000 total death.
• In some instances, the denominator may be related to total events instead of total population.
• E.g. in the case of motor vehicle accidents, the number of accidents “per 1000 vehicles” will be a more
useful denominator than the total population (as many of them may not be using a vehicle).
12
b) Related to total events
• This tool of measurement express a relation
in size between two random quantities.
• Numerator is not a component of the
denominator.
• The numerator and denominator may
involve an interval of time or may be
instantaneous in time.
Ratio is expressed as:
X: Y or 𝑿/𝒀 13
Ratio
Example:
• # beds per doctor
850 beds/10doctors
Ratio= 85 beds for 1 doctor
• Sex-ratio
• Dentist – population ratio
• A proportion indicates the relation in
magnitude of a part of the whole
(comparison of a part to the whole).
• Numerator is always included in the
denominator.
• Proportion is usually expressed as a
percentage.
14
Number of persons or events with a particular
characteristic (x)
Total number of persons or events, of which the
numerator is a subset(x+y)
∗ 100
𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 =
Proportion
Example:
Population- 3500 women, 6500 men
• Proportion of men=
6500/(3500+6500)
= 0.65 or 65 %
• M:F ratio = 6500/3500= 1.86
• F:M ratio =3500/6500=0.54
15
Measures of Disease Frequency
Population at risk
• Part of a population which is susceptible to a disease is called the population at risk.
• Risk factor is a characteristic which is more frequent in a group of subjects who develop a
certain disease than in subjects who do not develop the disease .
Risk is the probability of becoming ill, or the proportion of people who become ill (new cases)
during a specified time interval.
• The risk is therefore a proportion, its minimum value is 0 and maximum value is 1
• Population at risk can be defined on the basis of demographic or environmental
factors.
Risk = Number of new cases during a period of time
Population at risk at the beginning of period
• It is the number of new cases occurring in a
defined population during a specified period of
time.
Uses of incidence data
• Describe trends in diseases
• Evaluate impact of primary prevention
programmes
• Research into etiology, pathogenesis and
distribution of diseases
• helps in taking action to control disease.
16
Incidence Risk of disease
17
Incidence
Risk or cumulative incidence- is related to the population at risk at the beginning of the study period
Incidence risk=
Number of new cases of disease in a specified period of
time
Number of disease- free persons at the beginning of the
time period
Incidence rate=
Number of new cases of disease in a given time period
Total person-time at risk * during the study period
For e.g, some participants may : develop the outome under investigation, refuse to continue to participate
in the study, migrate, die, enter the study some time after it starts
Incidence rate/ incidence density-Is related to a more precise measure of the population at risk during the
study period and is measured in person-time units.
Difference between
incidence risk and
incidence rate and why
incidence rate is better
18
Refers to all current (old and new) cases existing at a given point in time or over a period of time in a given
population.
Point prevalence: Point prevalence of a disease is defined as the number of all current cases (old and new) of a
disease at one point of time, in relation to a defined population.
The “point” in the point prevalence, may for all practical purposes consist of a day, several days or even a few weeks
depending on the time it takes to examine the population sample.
Point prevalence =
Number of all current cases of a specific disease at a
given point of time
Estimated population at the same point in time
𝑥100
Prevalence Burden of disease
19
Point prevalence =
Number of all current cases of a specific disease at a
given point of time
Estimated population at the same point in time
𝑥100
Prevalence
Example:
Scenario:
• 150 children in a school
• Screening for refractory errors at time ‘t’
• 15 children require glasses
Prevalence of refractory errors = 15/150=10%
20
Period prevalence: Measures the frequency of all current (old and new) cases over a period of time (e.g. annual
prevalence) in a defined population.
Period prevalence =
Number of all current cases of a specific disease during a
given period of time interval
Estimated mid −interval population at risk
𝑥100
Example:
Scenario:
• Population of 150 persons
• Follow up for one year
• 25 had a disease of interest at the beginning
• Another 15 new cases developed during the year
Period prevalence=(25+15)/150=0.27 (27%)
Uses of prevalence data:
• Assessing health care needs
• Planning health services
• Measure occurrence of conditions with gradual onset
• Study chronic diseases
Causes of increase and decrease of prevalence:
Increase Decrease
• Long duration
• Low cure rate
• Low case fatality
• Increase in new cases
• Immigration of patients
• Improved detection
• Emigration of healthy people
• Shorter duration
• High cure rate
• High case fatality
• Decrease in new cases
• Emigration of patients
• Improved cure rate
• Immigration of healthy people
Changes in prevalence may have many causes and are difficult to interpret
Factors influencing prevalence:
• Number of new cases
• Duration of the illness
• If the disease is short, the prevalence is reduced
• The prevalence of sudden infant death = 0
• If the disease is long, the prevalence is increased
• Rare lifelong disease can accumulate to build up a large prevalence
23
Relationship between Prevalence (P) and Incidence (I)
P = I x D, where D is duration of illness
Change in prevalence from one time period to another may be the result of changes in
incidence rates, changes in the duration of disease, or both.
Patterns of incidence and prevalence
• High prevalence and low incidence
e.g., Diabetes Mellitus
• Low prevalence and high incidence
e.g., Common cold
24
Other commonly used measures of disease frequency in epidemiology
Mortality rates and ratios:
Crude death rate
= Number of deaths during the year
Mid-year population
𝑥1000
Specific death rate due to tuberculosis
=
Number of deaths from TB during a calendar year
Mid-year population
𝑥1000
=
Total number of deaths due to a particular disease
Total number of cases due to the same disease
𝑥100
Case fatality rate (ratio)
25
Proportional mortality rate (ratio) from a specific disease
= Number of deaths from the specific disease in a year
Total deaths from all causes in that year
𝑥100
Survival rate
=
Total number of patients alive after 5 years
Total number of patient diagnosed or treated
𝑥100
Morbidity:
Attack rate
Number of new cases of a specified disease
during a specified time interval
Total population at risk during the same
interval
𝑥100
=
Other commonly used measures of disease frequency in epidemiology
Primary attack rate-
primary source
Secondary attack rate-
secondary source
Eg: coronavirus
• quantifies the relationship between exposure and outcome.
• compare measures of disease occurrence among the exposed and unexposed groups.
Measures of association are –
• Relative Risk (RR)
• Odds Ratio (OR)
26
Measures of Association
27
Measures of Association- 2X2 Table
Outcome
Total
Yes No
Exposure
Yes a b a+b
No c d c+d
Total a+c b+d N
• Also known as Risk Ratio
• Defined as the ratio between the incidence of disease among exposed persons and incidence among non-
exposed.
• Relative Risk can be exactly determined only from a cohort study.
Relative Risk (RR)
RR =
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
Null value is 1 (divide)
Relative Risk (RR)
Interpretation of RR:
• RR =1; identical risk among 2 groups (no association between exposure & outcome)
• RR > 1; increased risk for the exposed group (positive association) (risk factor)
• RR < 1; decreased risk for the exposed group (negative association; exposure protects against disease occurrence)
Lung cancer
Lung cancer
absent
Smokers
(exposed)
15 (a) 45 (b)
Non-smokers
(unexposed)
6(c ) 24 (d)
Example:
RR = 𝑎/𝑎+𝑏÷𝑐/𝑐+𝑑
= (15/60)/(6/30)
= 1.25
RR =
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
Interpretation: The risk of smokers developing lung cancer
is 1.25 times higher than non smokers.
30
• Also known as Cross Product Ratio
• Measure of the strength of association between risk factor and outcome.
• Odds ratio is the key parameter in the analysis of case control studies.
• It is based on three assumptions:
a) the disease being investigated must be relatively rare
b) the cases must be representative of those with the disease
c)the controls must be representative of those without the disease
Odds Ratio (OR)
31
Odds Ratio (OR)
Interpretation of OR:
• OR =1; No association between exposure and outcome
• OR > 1; positive association(risk factor)
• OR < 1; negative association (protective factor)
Lung cancer
Lung cancer
absent
Smokers
(exposed)
17 (a) 83 (b)
Non-smokers
(unexposed)
1(c ) 99 (d)
•Odds in exposed group (a/b) = (smokers with
lung cancer) / (smokers without lung cancer) =
17/83 = 0.205
•Odds in not exposed group (c/d) = (non-
smokers with lung cancer) / (non-smokers
without lung cancer) = 1/99 = 0.01
•Odds ratio (ad/bc)= (odds in exposed group) /
(odds in not exposed group) = 0.205 / 0.01 =
20.5
Example:
Interpretation: Smokers showed a
risk of having lung cancer 20.5
times that of non -smokers
• Also known as risk difference or absolute risk reduction
This measure indicates the
• extent to which the disease under study can be attributed to the exposure.
• It is the difference in incidence rates of disease between an exposed group and non-exposed
group.
32
Measures of Impact-
Attributable risk (AR)
AR = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
Null value is 0 (differnce)
Cigarette
smoking
Lung cancer
Lung cancer
absent
Smokers
(exposed)
800 200
Non-smokers
(unexposed)
40 1960
Example:
AR%= 800-40/ 800 x 100
= 95%
AR% =
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛
𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝑥100
AR % =
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜
𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝑥100
Attributable Risk percent :
Interpretation: 95% of lung cancer among
smokers is due to smoking
Population Attributable Risk:
Incidence in the general population- incidence in the unexposed population
Amount of risk that would be eliminated from the general population if the exposure were eliminated
Population Attributable Risk percent (PAR%):
Incidence in the general population- incidence in the unexposed population
Incidence in the general population
General population =
62
100,000
Non-smokers =
7
100,000
PAR =62-7= 55 deaths per 100,000
PAR% = 62-7/62=0.89X100=89%
Example:
• Excess risk is the difference between the incidence rate among exposed and non-exposed
groups.
• Base line risk is the incidence of disease among non-exposed group.
• Number Needed to Harm (NNH) or Number Needed to Treat(NNT):
• Measure of the number of people who need to be exposed to a risk factor (or a
treatment) for one person to have a particular adverse effect (or to prevent an additional
bad outcome).
• NNH (or NNT) is the reciprocal of attributable risk- NNT= 1/AR
• Lower the NNH- more the risk of harm
35
Summary
Summary
Absolute Risk
The absolute risk of an event is a likelihood of occurrence of that event in the population at risk.
i.e the absolute risk is the probability of an event in a sample or population of interest.
It is expressed a s percentage , also in terms of person-years of exposure to the risk factor.
Absolute risk of an event=
Number of persons who experience the event
Total number of persons exposed to the risk of that
event
𝑥1000
Summary
• Risk: the probability of an outcome
• Relative risk is a measure of the strength of association and possibility of a causal relationship
• Attributable risk indicates the potential for prevention if the exposure could be eliminated.
• The comparisons like observed amount of disease in a population with the expected amount of
disease, can be quantified by using such measures of association as risk ratios, rate ratios, and
odds ratios. These measures provide evidence regarding causal relationships between exposures
and disease.
• RR is the risk of an event in an experimental group relative to that of control group
• OR is the odds of an event in an experimental group relative to that of control group
Reference
1. Park, Park’s Textbook of Preventive &Social Medicine, 25th Edition, Jabalpur: Banarsidas
Bhanot,2019.
2. Dicker RC, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice;
an introduction to applied epidemiology and biostatistics.
3. Noordzij M, Dekker FW, Zoccali C, Jager KJ. Measures of disease frequency: prevalence and
incidence. Nephron Clinical Practice. 2010;115(1):c17-20.
4. Hennekens CH, Buring JE. Epidemiology in Medicine, Lippincott Williams & Wilkins, 1987.
5. Rothman KJ. Epidemiology: an introduction. Oxford university press; 2012 May 4.
6. Mehendale S, Murhekar MV, Ramakrishnan R. NOC: Health Research Fundamentals.

More Related Content

Similar to MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT

4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
OwomugishaMartin
 
epidemiological measures.pptx
epidemiological measures.pptxepidemiological measures.pptx
epidemiological measures.pptx
NimrahFarooq4
 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf
SondosAli13
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
Dhan Pandey
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
Palwasha Khan
 
Unit 2
Unit 2Unit 2
Unit 2
minusth
 
3 Measurment new.pptx
3 Measurment new.pptx3 Measurment new.pptx
3 Measurment new.pptx
Gashawudesta
 
Chapter 3Measures of Morbidity and Mortality Used in .docx
Chapter 3Measures of Morbidity and Mortality Used in .docxChapter 3Measures of Morbidity and Mortality Used in .docx
Chapter 3Measures of Morbidity and Mortality Used in .docx
keturahhazelhurst
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
ADIL .
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
Dr Venkatesh Karthikeyan
 
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptxLECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
Ivwananjisikombe1
 
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptxEPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
TofikMohammadMuse
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
INAAMUL HAQ
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
Drsadhana Meena
 
Data incidence
Data incidenceData incidence
Data incidence
Pournami Dathan
 
Medical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdfMedical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdf
LuckyBoyCount
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
mehr92
 
Measurements of morbidity & mortality Jaya.pptx
Measurements of morbidity & mortality Jaya.pptxMeasurements of morbidity & mortality Jaya.pptx
Measurements of morbidity & mortality Jaya.pptx
jayalakshmi707175
 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptx
anjalatchi
 
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam AggarwalBasics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Dr. Sonam Aggarwal
 

Similar to MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT (20)

4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
 
epidemiological measures.pptx
epidemiological measures.pptxepidemiological measures.pptx
epidemiological measures.pptx
 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
 
Epidemilogy
EpidemilogyEpidemilogy
Epidemilogy
 
Unit 2
Unit 2Unit 2
Unit 2
 
3 Measurment new.pptx
3 Measurment new.pptx3 Measurment new.pptx
3 Measurment new.pptx
 
Chapter 3Measures of Morbidity and Mortality Used in .docx
Chapter 3Measures of Morbidity and Mortality Used in .docxChapter 3Measures of Morbidity and Mortality Used in .docx
Chapter 3Measures of Morbidity and Mortality Used in .docx
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
 
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptxLECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
 
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptxEPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
 
Epidemiology lecture3 incidence
Epidemiology lecture3 incidenceEpidemiology lecture3 incidence
Epidemiology lecture3 incidence
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
 
Data incidence
Data incidenceData incidence
Data incidence
 
Medical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdfMedical Surveillance and Outbreaks of Disease.pdf
Medical Surveillance and Outbreaks of Disease.pdf
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
 
Measurements of morbidity & mortality Jaya.pptx
Measurements of morbidity & mortality Jaya.pptxMeasurements of morbidity & mortality Jaya.pptx
Measurements of morbidity & mortality Jaya.pptx
 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptx
 
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam AggarwalBasics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
Basics of Epidemiology and Descriptive epidemiology by Dr. Sonam Aggarwal
 

More from Aneesa K Ayoob

DENTISTS ACT
DENTISTS ACTDENTISTS ACT
DENTISTS ACT
Aneesa K Ayoob
 
PIT AND FISSURE SEALANTS
PIT AND FISSURE SEALANTSPIT AND FISSURE SEALANTS
PIT AND FISSURE SEALANTS
Aneesa K Ayoob
 
CONSUMER PROTECTION ACT (CPA)
CONSUMER PROTECTION ACT (CPA)CONSUMER PROTECTION ACT (CPA)
CONSUMER PROTECTION ACT (CPA)
Aneesa K Ayoob
 
ETHICS
ETHICSETHICS
DENTAL AUXILIARY
DENTAL AUXILIARYDENTAL AUXILIARY
DENTAL AUXILIARY
Aneesa K Ayoob
 
SCHOOL ORAL HEALTH PROGRAMMES
SCHOOL ORAL HEALTH PROGRAMMESSCHOOL ORAL HEALTH PROGRAMMES
SCHOOL ORAL HEALTH PROGRAMMES
Aneesa K Ayoob
 
EPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCEREPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCER
Aneesa K Ayoob
 
SOCIAL SCIENCE
SOCIAL SCIENCESOCIAL SCIENCE
SOCIAL SCIENCE
Aneesa K Ayoob
 
HEALTH CARE DELIVERY
HEALTH CARE DELIVERYHEALTH CARE DELIVERY
HEALTH CARE DELIVERY
Aneesa K Ayoob
 
SCREENING TESTS
SCREENING TESTSSCREENING TESTS
SCREENING TESTS
Aneesa K Ayoob
 
TOBACCO CESSATION
TOBACCO CESSATIONTOBACCO CESSATION
TOBACCO CESSATION
Aneesa K Ayoob
 
AIR POLLUTION
AIR POLLUTIONAIR POLLUTION
AIR POLLUTION
Aneesa K Ayoob
 
ORAL HEALTH PROGRAM – A CASE STUDY FROM US
ORAL HEALTH PROGRAM – A CASE STUDY FROM USORAL HEALTH PROGRAM – A CASE STUDY FROM US
ORAL HEALTH PROGRAM – A CASE STUDY FROM US
Aneesa K Ayoob
 
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
Aneesa K Ayoob
 
ORAL HEALTHCARE DELIVERY IN INIDA
ORAL HEALTHCARE DELIVERY IN INIDAORAL HEALTHCARE DELIVERY IN INIDA
ORAL HEALTHCARE DELIVERY IN INIDA
Aneesa K Ayoob
 
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTIONPUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
Aneesa K Ayoob
 
CURRENT CONCEPTS OF FLOURIDE USE
CURRENT CONCEPTS OF FLOURIDE USECURRENT CONCEPTS OF FLOURIDE USE
CURRENT CONCEPTS OF FLOURIDE USE
Aneesa K Ayoob
 
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIESTRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
Aneesa K Ayoob
 
SYSTEM THINKING IN PUBLIC HEALTH
SYSTEM THINKING IN PUBLIC HEALTHSYSTEM THINKING IN PUBLIC HEALTH
SYSTEM THINKING IN PUBLIC HEALTH
Aneesa K Ayoob
 
BURDEN OF ORAL DISEASES
BURDEN OF ORAL DISEASESBURDEN OF ORAL DISEASES
BURDEN OF ORAL DISEASES
Aneesa K Ayoob
 

More from Aneesa K Ayoob (20)

DENTISTS ACT
DENTISTS ACTDENTISTS ACT
DENTISTS ACT
 
PIT AND FISSURE SEALANTS
PIT AND FISSURE SEALANTSPIT AND FISSURE SEALANTS
PIT AND FISSURE SEALANTS
 
CONSUMER PROTECTION ACT (CPA)
CONSUMER PROTECTION ACT (CPA)CONSUMER PROTECTION ACT (CPA)
CONSUMER PROTECTION ACT (CPA)
 
ETHICS
ETHICSETHICS
ETHICS
 
DENTAL AUXILIARY
DENTAL AUXILIARYDENTAL AUXILIARY
DENTAL AUXILIARY
 
SCHOOL ORAL HEALTH PROGRAMMES
SCHOOL ORAL HEALTH PROGRAMMESSCHOOL ORAL HEALTH PROGRAMMES
SCHOOL ORAL HEALTH PROGRAMMES
 
EPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCEREPIDEMIOLOGY OF ORAL CANCER
EPIDEMIOLOGY OF ORAL CANCER
 
SOCIAL SCIENCE
SOCIAL SCIENCESOCIAL SCIENCE
SOCIAL SCIENCE
 
HEALTH CARE DELIVERY
HEALTH CARE DELIVERYHEALTH CARE DELIVERY
HEALTH CARE DELIVERY
 
SCREENING TESTS
SCREENING TESTSSCREENING TESTS
SCREENING TESTS
 
TOBACCO CESSATION
TOBACCO CESSATIONTOBACCO CESSATION
TOBACCO CESSATION
 
AIR POLLUTION
AIR POLLUTIONAIR POLLUTION
AIR POLLUTION
 
ORAL HEALTH PROGRAM – A CASE STUDY FROM US
ORAL HEALTH PROGRAM – A CASE STUDY FROM USORAL HEALTH PROGRAM – A CASE STUDY FROM US
ORAL HEALTH PROGRAM – A CASE STUDY FROM US
 
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
EFFECTIVENESS OF THE SCHOOL-BASED ORAL PREVENTION PROGRAMS
 
ORAL HEALTHCARE DELIVERY IN INIDA
ORAL HEALTHCARE DELIVERY IN INIDAORAL HEALTHCARE DELIVERY IN INIDA
ORAL HEALTHCARE DELIVERY IN INIDA
 
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTIONPUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
PUBLIC HEALTH APPROACHES FOR ORAL DISEASE PREVENTION
 
CURRENT CONCEPTS OF FLOURIDE USE
CURRENT CONCEPTS OF FLOURIDE USECURRENT CONCEPTS OF FLOURIDE USE
CURRENT CONCEPTS OF FLOURIDE USE
 
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIESTRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
TRENDS IN EPIDEMIOLOGY OF DENTAL CARIES
 
SYSTEM THINKING IN PUBLIC HEALTH
SYSTEM THINKING IN PUBLIC HEALTHSYSTEM THINKING IN PUBLIC HEALTH
SYSTEM THINKING IN PUBLIC HEALTH
 
BURDEN OF ORAL DISEASES
BURDEN OF ORAL DISEASESBURDEN OF ORAL DISEASES
BURDEN OF ORAL DISEASES
 

Recently uploaded

CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT

  • 1. Measures of Disease Frequency, Association and Impact SEMINAR NO: 5 1
  • 2. Contents 1. Rationale for measurement of health and disease 2. Tools of measurement 3. Measures of disease frequency 4. Measures of association 5. Measures of impact 6. Summary 7. References 2
  • 3. Rationale Measurement of health and disease is important due to the following reasons: a. Need for data to guide efforts towards reducing the consequences of disease b. To understand and assess health status of a population and its changes with time c. Need for evidence-based decisions in healthcare 3
  • 4. How do we measure disease? 4 Count Divide Compare
  • 5. These are: Count, Rate, Ratio, Proportion Count: • Simplest and most basic form of measurement. • It represents the number of individuals who meet the case definition. • Limitation: (i) Count do not consider the size of population at risk (ii)Count do not specify the time of observation Tools of measurement- Count 5
  • 6. Count 6 Example: Count: Number of new cases Year Population City A 58 1990 25,000 City B 35 1989-90 7,000 Divide: City A (58/25,000)/1 year=0.00232 City B (35/7,000)/2 years= 0.0025 Compare: City A 232/100,000 per year City B 250/100,000 per year
  • 7. Common tools of measurement used in research are – rate, ratio, proportion. Basic formula: • Numerator - count of an event in a population during a specific time period. • Denominator - population pool Tools of measurement ꭓ 10𝑛 𝑁𝑢𝑚𝑒𝑟𝑎𝑡𝑜𝑟 𝐷𝑒𝑛𝑜𝑚𝑖𝑛𝑎𝑡𝑜𝑟 7 What is in the denominator?
  • 8. • Measures the occurrence of an event in a defined population during a given period of time. • It is a statement of the risk of developing a condition and is used for comparison between different locations, time periods or groups. • E.g., death rate and is given by the formula: Death rate = 8 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑡ℎ𝑠 𝑖𝑛 𝑜𝑛𝑒 𝑦𝑒𝑎𝑟 𝑀𝑖𝑑 − 𝑦𝑒𝑎𝑟 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 ∗ 1000 Rate Rate- expressed per 1000 or round figure (10,000;100,000) selected according to convenience to avoid fractions. numerator denominator time multiplier
  • 9. • Concept of numerator in rate: Numerator is a component of denominator in calculating a rate. • Concept of denominator in rate: Appropriate denominator should be chosen to calculate a rate. 9 Denominator Related to Population Mid year population Population at risk Person-time Subgroups of the population Related to Total events
  • 10. 10 Mid -year population • The population size changes daily due to births, deaths or migration. •Mid-point refers to the population estimated as on first of July of a year. Population at risk •Focus is on the groups at risk of disease rather than on individuals. • The concept of ‘population at risk’ is restricted solely to those who are capable of having or acquiring the disease or condition in question. Person -time • When persons enter the study at different times, they are under observation for varying time period. •In such cases the denominator is a combination of persons and time (as in person -years, person -months, person - weeks or man- hours). •Person – distance is a variant of person – time as in passenger -miles. Sub-groups of the population •Denominator may be subgroup of a population •e.g., age, gender, occupation etc. These denominators have the advantage of summarizing the experience of persons with different durations of observation or exposure. a) Related to the population:
  • 11. Example: Mortality rate of tetanus in Monduli in 1995 Tetanus deaths: 17 Population in 1995: 58 million Mortality rate =0.029/ 100,000 per year The number of death due to tetanus is 2900 per 100,000 total death.
  • 12. • In some instances, the denominator may be related to total events instead of total population. • E.g. in the case of motor vehicle accidents, the number of accidents “per 1000 vehicles” will be a more useful denominator than the total population (as many of them may not be using a vehicle). 12 b) Related to total events
  • 13. • This tool of measurement express a relation in size between two random quantities. • Numerator is not a component of the denominator. • The numerator and denominator may involve an interval of time or may be instantaneous in time. Ratio is expressed as: X: Y or 𝑿/𝒀 13 Ratio Example: • # beds per doctor 850 beds/10doctors Ratio= 85 beds for 1 doctor • Sex-ratio • Dentist – population ratio
  • 14. • A proportion indicates the relation in magnitude of a part of the whole (comparison of a part to the whole). • Numerator is always included in the denominator. • Proportion is usually expressed as a percentage. 14 Number of persons or events with a particular characteristic (x) Total number of persons or events, of which the numerator is a subset(x+y) ∗ 100 𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 = Proportion Example: Population- 3500 women, 6500 men • Proportion of men= 6500/(3500+6500) = 0.65 or 65 % • M:F ratio = 6500/3500= 1.86 • F:M ratio =3500/6500=0.54
  • 15. 15 Measures of Disease Frequency Population at risk • Part of a population which is susceptible to a disease is called the population at risk. • Risk factor is a characteristic which is more frequent in a group of subjects who develop a certain disease than in subjects who do not develop the disease . Risk is the probability of becoming ill, or the proportion of people who become ill (new cases) during a specified time interval. • The risk is therefore a proportion, its minimum value is 0 and maximum value is 1 • Population at risk can be defined on the basis of demographic or environmental factors. Risk = Number of new cases during a period of time Population at risk at the beginning of period
  • 16. • It is the number of new cases occurring in a defined population during a specified period of time. Uses of incidence data • Describe trends in diseases • Evaluate impact of primary prevention programmes • Research into etiology, pathogenesis and distribution of diseases • helps in taking action to control disease. 16 Incidence Risk of disease
  • 17. 17 Incidence Risk or cumulative incidence- is related to the population at risk at the beginning of the study period Incidence risk= Number of new cases of disease in a specified period of time Number of disease- free persons at the beginning of the time period Incidence rate= Number of new cases of disease in a given time period Total person-time at risk * during the study period For e.g, some participants may : develop the outome under investigation, refuse to continue to participate in the study, migrate, die, enter the study some time after it starts Incidence rate/ incidence density-Is related to a more precise measure of the population at risk during the study period and is measured in person-time units. Difference between incidence risk and incidence rate and why incidence rate is better
  • 18. 18 Refers to all current (old and new) cases existing at a given point in time or over a period of time in a given population. Point prevalence: Point prevalence of a disease is defined as the number of all current cases (old and new) of a disease at one point of time, in relation to a defined population. The “point” in the point prevalence, may for all practical purposes consist of a day, several days or even a few weeks depending on the time it takes to examine the population sample. Point prevalence = Number of all current cases of a specific disease at a given point of time Estimated population at the same point in time 𝑥100 Prevalence Burden of disease
  • 19. 19 Point prevalence = Number of all current cases of a specific disease at a given point of time Estimated population at the same point in time 𝑥100 Prevalence Example: Scenario: • 150 children in a school • Screening for refractory errors at time ‘t’ • 15 children require glasses Prevalence of refractory errors = 15/150=10%
  • 20. 20 Period prevalence: Measures the frequency of all current (old and new) cases over a period of time (e.g. annual prevalence) in a defined population. Period prevalence = Number of all current cases of a specific disease during a given period of time interval Estimated mid −interval population at risk 𝑥100 Example: Scenario: • Population of 150 persons • Follow up for one year • 25 had a disease of interest at the beginning • Another 15 new cases developed during the year Period prevalence=(25+15)/150=0.27 (27%)
  • 21. Uses of prevalence data: • Assessing health care needs • Planning health services • Measure occurrence of conditions with gradual onset • Study chronic diseases Causes of increase and decrease of prevalence: Increase Decrease • Long duration • Low cure rate • Low case fatality • Increase in new cases • Immigration of patients • Improved detection • Emigration of healthy people • Shorter duration • High cure rate • High case fatality • Decrease in new cases • Emigration of patients • Improved cure rate • Immigration of healthy people Changes in prevalence may have many causes and are difficult to interpret
  • 22. Factors influencing prevalence: • Number of new cases • Duration of the illness • If the disease is short, the prevalence is reduced • The prevalence of sudden infant death = 0 • If the disease is long, the prevalence is increased • Rare lifelong disease can accumulate to build up a large prevalence
  • 23. 23 Relationship between Prevalence (P) and Incidence (I) P = I x D, where D is duration of illness Change in prevalence from one time period to another may be the result of changes in incidence rates, changes in the duration of disease, or both. Patterns of incidence and prevalence • High prevalence and low incidence e.g., Diabetes Mellitus • Low prevalence and high incidence e.g., Common cold
  • 24. 24 Other commonly used measures of disease frequency in epidemiology Mortality rates and ratios: Crude death rate = Number of deaths during the year Mid-year population 𝑥1000 Specific death rate due to tuberculosis = Number of deaths from TB during a calendar year Mid-year population 𝑥1000 = Total number of deaths due to a particular disease Total number of cases due to the same disease 𝑥100 Case fatality rate (ratio)
  • 25. 25 Proportional mortality rate (ratio) from a specific disease = Number of deaths from the specific disease in a year Total deaths from all causes in that year 𝑥100 Survival rate = Total number of patients alive after 5 years Total number of patient diagnosed or treated 𝑥100 Morbidity: Attack rate Number of new cases of a specified disease during a specified time interval Total population at risk during the same interval 𝑥100 = Other commonly used measures of disease frequency in epidemiology Primary attack rate- primary source Secondary attack rate- secondary source Eg: coronavirus
  • 26. • quantifies the relationship between exposure and outcome. • compare measures of disease occurrence among the exposed and unexposed groups. Measures of association are – • Relative Risk (RR) • Odds Ratio (OR) 26 Measures of Association
  • 27. 27 Measures of Association- 2X2 Table Outcome Total Yes No Exposure Yes a b a+b No c d c+d Total a+c b+d N
  • 28. • Also known as Risk Ratio • Defined as the ratio between the incidence of disease among exposed persons and incidence among non- exposed. • Relative Risk can be exactly determined only from a cohort study. Relative Risk (RR) RR = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 Null value is 1 (divide)
  • 29. Relative Risk (RR) Interpretation of RR: • RR =1; identical risk among 2 groups (no association between exposure & outcome) • RR > 1; increased risk for the exposed group (positive association) (risk factor) • RR < 1; decreased risk for the exposed group (negative association; exposure protects against disease occurrence) Lung cancer Lung cancer absent Smokers (exposed) 15 (a) 45 (b) Non-smokers (unexposed) 6(c ) 24 (d) Example: RR = 𝑎/𝑎+𝑏÷𝑐/𝑐+𝑑 = (15/60)/(6/30) = 1.25 RR = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 Interpretation: The risk of smokers developing lung cancer is 1.25 times higher than non smokers.
  • 30. 30 • Also known as Cross Product Ratio • Measure of the strength of association between risk factor and outcome. • Odds ratio is the key parameter in the analysis of case control studies. • It is based on three assumptions: a) the disease being investigated must be relatively rare b) the cases must be representative of those with the disease c)the controls must be representative of those without the disease Odds Ratio (OR)
  • 31. 31 Odds Ratio (OR) Interpretation of OR: • OR =1; No association between exposure and outcome • OR > 1; positive association(risk factor) • OR < 1; negative association (protective factor) Lung cancer Lung cancer absent Smokers (exposed) 17 (a) 83 (b) Non-smokers (unexposed) 1(c ) 99 (d) •Odds in exposed group (a/b) = (smokers with lung cancer) / (smokers without lung cancer) = 17/83 = 0.205 •Odds in not exposed group (c/d) = (non- smokers with lung cancer) / (non-smokers without lung cancer) = 1/99 = 0.01 •Odds ratio (ad/bc)= (odds in exposed group) / (odds in not exposed group) = 0.205 / 0.01 = 20.5 Example: Interpretation: Smokers showed a risk of having lung cancer 20.5 times that of non -smokers
  • 32. • Also known as risk difference or absolute risk reduction This measure indicates the • extent to which the disease under study can be attributed to the exposure. • It is the difference in incidence rates of disease between an exposed group and non-exposed group. 32 Measures of Impact- Attributable risk (AR) AR = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 Null value is 0 (differnce)
  • 33. Cigarette smoking Lung cancer Lung cancer absent Smokers (exposed) 800 200 Non-smokers (unexposed) 40 1960 Example: AR%= 800-40/ 800 x 100 = 95% AR% = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛 𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑥100 AR % = 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 −𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜 𝑛𝑔 𝑛𝑜𝑛 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑒 𝑎𝑚𝑜𝑛𝑔 𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑥100 Attributable Risk percent : Interpretation: 95% of lung cancer among smokers is due to smoking
  • 34. Population Attributable Risk: Incidence in the general population- incidence in the unexposed population Amount of risk that would be eliminated from the general population if the exposure were eliminated Population Attributable Risk percent (PAR%): Incidence in the general population- incidence in the unexposed population Incidence in the general population General population = 62 100,000 Non-smokers = 7 100,000 PAR =62-7= 55 deaths per 100,000 PAR% = 62-7/62=0.89X100=89% Example:
  • 35. • Excess risk is the difference between the incidence rate among exposed and non-exposed groups. • Base line risk is the incidence of disease among non-exposed group. • Number Needed to Harm (NNH) or Number Needed to Treat(NNT): • Measure of the number of people who need to be exposed to a risk factor (or a treatment) for one person to have a particular adverse effect (or to prevent an additional bad outcome). • NNH (or NNT) is the reciprocal of attributable risk- NNT= 1/AR • Lower the NNH- more the risk of harm 35
  • 38. Absolute Risk The absolute risk of an event is a likelihood of occurrence of that event in the population at risk. i.e the absolute risk is the probability of an event in a sample or population of interest. It is expressed a s percentage , also in terms of person-years of exposure to the risk factor. Absolute risk of an event= Number of persons who experience the event Total number of persons exposed to the risk of that event 𝑥1000
  • 39. Summary • Risk: the probability of an outcome • Relative risk is a measure of the strength of association and possibility of a causal relationship • Attributable risk indicates the potential for prevention if the exposure could be eliminated. • The comparisons like observed amount of disease in a population with the expected amount of disease, can be quantified by using such measures of association as risk ratios, rate ratios, and odds ratios. These measures provide evidence regarding causal relationships between exposures and disease. • RR is the risk of an event in an experimental group relative to that of control group • OR is the odds of an event in an experimental group relative to that of control group
  • 40. Reference 1. Park, Park’s Textbook of Preventive &Social Medicine, 25th Edition, Jabalpur: Banarsidas Bhanot,2019. 2. Dicker RC, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice; an introduction to applied epidemiology and biostatistics. 3. Noordzij M, Dekker FW, Zoccali C, Jager KJ. Measures of disease frequency: prevalence and incidence. Nephron Clinical Practice. 2010;115(1):c17-20. 4. Hennekens CH, Buring JE. Epidemiology in Medicine, Lippincott Williams & Wilkins, 1987. 5. Rothman KJ. Epidemiology: an introduction. Oxford university press; 2012 May 4. 6. Mehendale S, Murhekar MV, Ramakrishnan R. NOC: Health Research Fundamentals.

Editor's Notes

  1. Components of rate
  2. For every 1 dr 85 beds are there
  3. Incidence and prevalence are two measures of frequency that are used to characterize the occurrence of health event in a population.
  4. To account for these variations during follow up, a more precise measure can be calculated, the incidence rate .
  5. Prevalence is of two types – Point prevalence, Period prevalence.
  6. Prevalence is of two types – Point prevalence, Period prevalence.
  7. Used to summarize frequencies of disease and exposure and used for calculation of association Sometimes called as contingency tables Used tor ecord and analyze relationships Lists outcomes in the column List exposures in the rows Cell data Are counts
  8. 1 or greater indicates- greater indicates an increased risk A relative risk less than 1 indicates a decreased risk the risk of smokers developing lung cancer is 1.25 times higher than non smokers
  9. 89% of risk due to exposure